We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne profile page

Managing Editor

 at Technology Networks


As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Education


University of Kent  

Nottingham Trent University  


Areas of Expertise



Got a Question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 409
Article

Detecting Cancer Earlier: The Importance of Collaboration, Funding and Technology

We recently spoke to Dr David Crosby, Head of Early Detection Research, Research and Innovation, Cancer Research UK, to learn more about the importance of early cancer detection.
Industry Insight

Optimizing Data Visualization and Analysis for Biologics Discovery

This blog discusses the challenges associated with harnessing large data sets and the implications that could arise from the inability to sufficiently access, share and analyze scientific data in terms of biopharmaceutical and small molecule discovery.
Industry Insight

Harnessing Big Data in the Fight Against Pediatric Cancer

We recently spoke to Dr Samuel L. Volchenboum to learn more about his current research within the areas of pediatric cancer and inflammatory bowel disease. He discusses current challenges of harnessing data and informatics, and strategies for optimizing data to enhance the impact of research.
Industry Insight

Handling Potent Active Pharmaceutical Ingredients

APIs are a critical component of the pharmaceutical supply chain, and it is important that biopharmaceutical companies integrate potent API management and handling concepts in to their daily operations. We spoke to Justin Mason-Home, to learn more about the importance of applying robust occupational health and safety processes to the drug discovery and development pipeline.
Article

The Link Between Cancer and Obesity

A growing amount of evidence proposes that several types of cancer are more common in overweight or obese people and that cancer risk is increased in those with higher body fat.
News

Immune Cells Hunt Down Deadly Brain Tumors Thanks to Novel Target Molecule

Scientists have successfully genetically engineered immune cells to hunt down and target brain tumors, thanks to the discovery of a novel molecular target, CSPG4, present on the surface of the cancer cells.
Industry Insight

Adopting a Data-Driven Approach to Optimize Clinical Trial Research

TriNetX is a global health research network, that brings together healthcare organizations, clinical research organizations and biopharmaceutical companies with a mission to enhance clinical trial design, accelerate study recruitment, to ultimately make new therapies available to patients faster.
4 Antibody Display Platforms for Detecting Lead Antibody Candidates content piece image
Listicle

4 Antibody Display Platforms for Detecting Lead Antibody Candidates

Automating display technologies is strengthening scientist’s abilities to detect multiple lead antibody candidates for a single therapeutic target.
Industry Insight

How to Address Data Integrity Challenges

Data integrity continues to be a hot topic for regulatory agencies in the pharmaceutical industry. Companies are making tremendous efforts to ensure their data integrity capabilities are robust. We spoke to two experts, to learn more about how Chromeleon can help demonstrate regulatory compliance and help overcome CDS data integrity challenges.
Article

World Cancer Day: Unite the Fight Against Cancer

World Cancer Day takes place on February 4 each year. This global event aims to ‘unite the fight’ against cancer and raise awareness of the disease. To mark this day, we have compiled some key cancer facts and a selection of the latest research developments.
Advertisement